biosimilars

News

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Roche’s pharmaceutical revenues have been hit by falling sales in its pharma division in Q3 but a spike in demand for COVID-19 tests spared the Swiss company's blushes.

News

Amgen's cancer biosimilars stay on US market as court battle...

Amgen has scored yet another home run in the US courts, this time seeing off a legal challenge from Genentech, which was trying to block it from launching two cut-price cancer biosimilars.

Views & Analysis

Breaking policy and perceptual barriers: Biosimilars

Experts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted the adoption of biosimilars.

Views & Analysis

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

News

Merck & Co spin off could start a trend in big pharma

Merck & Co’s strategy to spin off its older drugs and biosimilars into a new stand-alone business will be closely watched by other pharma companies considering the same move, analysts h

Views & Analysis

3 key trends shaping the immunology market

From an increase in sales of interleukin inhibitors to the prevalence of biosimilars, this decade has been an eventful one in the immunology industry.

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Amgen's cancer biosimilars stay on US market as court battle...

Breaking policy and perceptual barriers: Biosimilars

Deep Dive: Market Access - Breaking Barriers

Merck & Co spin off could start a trend in big pharma

3 key trends shaping the immunology market

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

biosimilars

Editor's Picks